Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)

Circulating tumor DNA (ctDNA) has emerged as a promising biomarker of minimal residual disease (MRD) in solid tumors. There is increasing evidence to suggest that the detection of ctDNA following curative-intent treatments has high potential in anticipating future relapse in various solid tumors. Mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Huijuan, Zhou, Qiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152452/
https://www.ncbi.nlm.nih.gov/pubmed/37052271
http://dx.doi.org/10.3892/or.2023.8543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152452/
https://www.ncbi.nlm.nih.gov/pubmed/37052271
http://dx.doi.org/10.3892/or.2023.8543

Ejemplares similares